Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Equity (2020 - 2023)

Terns Pharmaceuticals' Return on Equity history spans 4 years, with the latest figure at 0.32% for Q3 2023.

  • For Q3 2023, Return on Equity rose 5.0% year-over-year to 0.32%; the TTM value through Sep 2023 reached 0.32%, up 5.0%, while the annual FY2022 figure was 0.28%, 206.0% up from the prior year.
  • Return on Equity reached 0.32% in Q3 2023 per TERN's latest filing, down from 0.26% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2020 to a low of 0.38% in Q2 2022.
  • Average Return on Equity over 4 years is 0.22%, with a median of 0.26% recorded in 2022.
  • Peak YoY movement for Return on Equity: crashed -35bps in 2022, then increased 12bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 0.0% in 2020, then plummeted by -9652bps to 0.3% in 2021, then increased by 13bps to 0.26% in 2022, then dropped by -22bps to 0.32% in 2023.
  • Per Business Quant, the three most recent readings for TERN's Return on Equity are 0.32% (Q3 2023), 0.26% (Q2 2023), and 0.24% (Q1 2023).